Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Mortality benefits of influenza vaccination in elderly people: an ongoing controversy.

Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA.

Lancet Infect Dis. 2007 Oct;7(10):658-66. Review.

PMID:
17897608
2.

Mortality benefits of influenza vaccination in elderly people.

Thijs C, Beyer WE, Govaert PM, Sprenger MJ, Dinant GJ, Knottnerus A.

Lancet Infect Dis. 2008 Aug;8(8):460-1; author reply 463-5. doi: 10.1016/S1473-3099(08)70161-0. No abstract available.

PMID:
18652989
3.

Influenza vaccination and mortality benefits: new insights, new opportunities.

Simonsen L, Viboud C, Taylor RJ, Miller MA, Jackson L.

Vaccine. 2009 Oct 23;27(45):6300-4. doi: 10.1016/j.vaccine.2009.07.008.

PMID:
19840664
4.

Mortality benefits of influenza vaccination in elderly people.

Kelly H, Newall AT.

Lancet Infect Dis. 2008 Aug;8(8):462-3; author reply 463-5. doi: 10.1016/S1473-3099(08)70163-4. No abstract available.

PMID:
18652991
5.

Mortality benefits of influenza vaccination in elderly people.

Voordouw BC, Sturkenboom MC, Dieleman JP, Stricker BH.

Lancet Infect Dis. 2008 Aug;8(8):461-2; author reply 463-5. doi: 10.1016/S1473-3099(08)70162-2. No abstract available.

PMID:
18652990
6.

Impact of influenza vaccination on seasonal mortality in the US elderly population.

Simonsen L, Reichert TA, Viboud C, Blackwelder WC, Taylor RJ, Miller MA.

Arch Intern Med. 2005 Feb 14;165(3):265-72.

PMID:
15710788
7.

AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial.

McElhaney JE, Beran J, Devaster JM, Esen M, Launay O, Leroux-Roels G, Ruiz-Palacios GM, van Essen GA, Caplanusi A, Claeys C, Durand C, Duval X, El Idrissi M, Falsey AR, Feldman G, Frey SE, Galtier F, Hwang SJ, Innis BL, Kovac M, Kremsner P, McNeil S, Nowakowski A, Richardus JH, Trofa A, Oostvogels L; Influence65 study group.

Lancet Infect Dis. 2013 Jun;13(6):485-96. doi: 10.1016/S1473-3099(13)70046-X. Epub 2013 Mar 19.

PMID:
23518156
8.

Influenza vaccination for older adults.

Talbot HK, Libster R, Edwards KM.

Hum Vaccin Immunother. 2012 Jan;8(1):96-101. doi: 10.4161/hv.8.1.18129. Epub 2012 Jan 1. Review.

PMID:
22252003
9.

Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy.

Nichol KL.

Vaccine. 2009 Oct 23;27(45):6305-11. doi: 10.1016/j.vaccine.2009.07.006.

PMID:
19840665
10.

Selection bias in evaluating of influenza vaccine effectiveness: a lesson from an observational study of elderly nursing home residents.

Fukushima W, Hayashi Y, Mizuno Y, Suzuki K, Kase T, Ohfuji S, Fujieda M, Maeda A, Hirota Y.

Vaccine. 2008 Nov 25;26(50):6466-9. doi: 10.1016/j.vaccine.2008.06.038. Epub 2008 Jun 26.

PMID:
18582520
11.

Decline in influenza-associated mortality among Dutch elderly following the introduction of a nationwide vaccination program.

Jansen AG, Sanders EA, Nichol KL, van Loon AM, Hoes AW, Hak E.

Vaccine. 2008 Oct 16;26(44):5567-74. doi: 10.1016/j.vaccine.2008.08.003. Epub 2008 Aug 21.

PMID:
18722492
12.

Influenza vaccination for healthcare workers who work with the elderly.

Thomas RE, Jefferson T, Demicheli V, Rivetti D.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005187. Review. Update in: Cochrane Database Syst Rev. 2010;(2):CD005187.

PMID:
16856082
13.

Effects of annual influenza vaccination on winter mortality in elderly people with chronic heart disease.

de Diego C, Vila-Córcoles A, Ochoa O, Rodriguez-Blanco T, Salsench E, Hospital I, Bejarano F, Del Puy Muniain M, Fortin M, Canals M; EPIVAC Study Group.

Eur Heart J. 2009 Jan;30(2):209-16. doi: 10.1093/eurheartj/ehn498. Epub 2008 Nov 8.

PMID:
18997178
14.

Vaccines for preventing influenza in the elderly.

Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE.

Cochrane Database Syst Rev. 2010 Feb 17;(2):CD004876. doi: 10.1002/14651858.CD004876.pub3. Review.

PMID:
20166072
15.

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis.

Osterholm MT, Kelley NS, Sommer A, Belongia EA.

Lancet Infect Dis. 2012 Jan;12(1):36-44. doi: 10.1016/S1473-3099(11)70295-X. Epub 2011 Oct 25. Review. Erratum in: Lancet Infect Dis. 2012 Sep;12(9):655.

PMID:
22032844
16.

Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine.

Sullivan SJ, Jacobson R, Poland GA.

Expert Rev Vaccines. 2010 Oct;9(10):1127-33. doi: 10.1586/erv.10.117. Review.

PMID:
20923264
17.

Impact of influenza vaccination on mortality in the French elderly population during the 2000-2009 period.

Bonmarin I, Belchior E, Lévy-Bruhl D.

Vaccine. 2015 Feb 25;33(9):1099-101. doi: 10.1016/j.vaccine.2015.01.023. Epub 2015 Jan 17.

PMID:
25604800
18.

Immunogenicity of an inactivated split influenza vaccine in institutionalized elderly patients.

Van Hoecke C, Prikazsky V, Utö I, Menschikowski C.

Gerontology. 1996;42(4):190-8.

PMID:
8832266
19.

Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects.

Squarcione S, Sgricia S, Biasio LR, Perinetti E.

Vaccine. 2003 Mar 7;21(11-12):1268-74.

PMID:
12559808
20.

[The immunoprophylaxis of influenza among elderly persons].

Marinich IG, Paramonova MS, Erofeeva MK, Maksakova VL, Nikolaeva VM, Naĭkhin AN, Kraĭnova TI, Parkov OV.

Zh Mikrobiol Epidemiol Immunobiol. 1997 May-Jun;(3):60-4. Russian.

PMID:
9304332

Supplemental Content

Support Center